Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells
- 30 September 2010
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 90 (5), 301-305
- https://doi.org/10.1016/j.tube.2010.07.004
Abstract
No abstract availableKeywords
Funding Information
- Johnson and Johnson Pharmaceutical Research and Development
This publication has 9 references indexed in Scilit:
- The Diarylquinoline TMC207 for Multidrug-Resistant TuberculosisNew England Journal of Medicine, 2009
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary TuberculosisAntimicrobial Agents and Chemotherapy, 2008
- Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like Bacilli in Tuberculous SputumPLoS Medicine, 2008
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005
- Mycobacterium tuberculosis Resides in Nonacidified Vacuoles in Endocytically Competent Alveolar Macrophages from Patients with Tuberculosis and HIV InfectionThe Journal of Immunology, 2004
- Transcriptional Adaptation of Mycobacterium tuberculosis within MacrophagesThe Journal of Experimental Medicine, 2003
- Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated AdversaryAntimicrobial Agents and Chemotherapy, 2003
- Activityin vitroof Rifabutin, FCE 22807, Rifapentine, and Rifampin againstMycobacterium microtiandM. tuberculosisand Their Penetration into Mouse Peritoneal MacrophagesAmerican Review of Respiratory Disease, 1992
- Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254Antimicrobial Agents and Chemotherapy, 1989